Mankind Pharma, 543904, MANKIND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

94,869.36
54.93
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

94,454.06
N/A
10.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.51
-
12.08

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.70
-
2.89

PAT CAGR (%)

10 Years
5 Years
3 Years

13.75
-
0.43

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 2,358.57 1,936.23 21.81% 2,453.35 2,257.55 8.67% 2,300.21 2,061.25 11.59% 1,872.12 1,644.82 13.82%
Expenses 1,755.46 1,562.74 12.33% 1,818.15 1,735.21 4.78% 1,760.74 1,640.87 7.31% 1,490.96 1,335.62 11.63%
EBITDA 603.11 373.50 61.48% 635.19 522.34 21.60% 539.47 420.38 28.33% 381.16 309.20 23.27%
EBIDTM 25.57% 19.29% 25.89% 23.14% 23.45% 20.39% 20.36% 18.80%
Other Income 67.23 32.40 107.50% 58.12 69.15 -15.95% 57.44 18.78 205.86% 42.45 8.15 420.86%
Interest 4.26 9.24 -53.90% 4.31 8.19 -47.37% 1.97 9.43 -79.11% 0.89 10.61 -91.61%
Depreciation 89.73 71.02 26.34% 77.04 66.04 16.66% 68.54 65.22 5.09% 67.30 36.41 84.84%
PBT 576.35 325.64 76.99% 611.96 517.25 18.31% 526.39 364.51 44.41% 355.43 270.32 31.48%
Tax 89.28 76.76 16.31% 139.08 97.02 43.35% 117.11 66.35 76.50% 74.45 52.84 40.90%
PAT 487.07 248.87 95.71% 472.89 420.23 12.53% 409.28 298.16 37.27% 280.99 217.48 29.20%
PATM 20.65% 12.85% 19.28% 18.61% 17.79% 14.47% 15.01% 13.22%
EPS 12.16 6.21 95.81% 11.80 10.49 12.49% 10.22 7.44 37.37% 7.01 5.43 29.10%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 2,606.96 2,090.93 24.68% 2,708.10 2,425.84 11.64% 2,578.62 2,180.00 18.29% 2,052.67 1,725.76 18.94%
Expenses 2,000.45 1,653.89 20.95% 2,025.45 1,835.13 10.37% 1,923.80 1,723.79 11.60% 1,635.99 1,440.93 13.54%
EBITDA 606.50 437.04 38.77% 682.64 590.71 15.56% 654.82 456.20 43.54% 416.68 284.83 46.29%
EBIDTM 23.26% 20.90% 25.21% 24.35% 25.39% 20.93% 20.30% 16.50%
Other Income 70.13 37.14 88.83% 59.98 27.37 119.15% 58.62 16.54 254.41% 47.51 33.53 41.69%
Interest 9.18 12.77 -28.11% 8.62 10.31 -16.39% 6.34 16.24 -60.96% 5.15 13.03 -60.48%
Depreciation 109.73 84.79 29.41% 96.48 78.59 22.76% 87.35 78.02 11.96% 84.52 47.36 78.46%
PBT 557.73 376.63 48.08% 637.51 529.18 20.47% 619.74 378.49 63.74% 374.51 257.97 45.18%
Tax 102.52 83.27 23.12% 129.81 110.39 17.59% 130.28 84.32 54.51% 83.59 70.33 18.85%
PAT 455.21 293.36 55.17% 507.70 418.80 21.23% 489.46 294.17 66.39% 290.93 187.64 55.05%
PATM 17.46% 14.03% 18.75% 17.26% 18.98% 13.49% 14.17% 10.87%
EPS 11.33 7.09 59.80% 12.51 10.48 19.37% 12.15 7.30 66.44% 7.13 4.75 50.11%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 05
Net Sales 8,984.25 8,127.15 7,486.22 5,523.18 2,288.59 1,971.77 1,650.57 1,406.88 1,085.77 840.27 207.73 Net Sales Growth 13.73% 8.56% 35.54% 141.34% 16.07% 19.46% 17.32% 29.57% 29.22% 304.50% Cost Of Goods Sold 2,933.91 2,844.76 2,521.44 1,782.17 974.33 868.10 758.68 -109.37 495.66 400.20 117.74 Gross Profit 6,050.34 5,282.39 4,964.78 3,741.02 1,314.26 1,103.66 891.90 1,516.25 590.11 440.07 89.98 GP Margin 67.34% 65.00% 66.32% 67.73% 57.43% 55.97% 54.04% 107.77% 54.35% 52.37% 43.32% Total Expenditure 6,825.31 6,429.29 5,647.73 4,151.05 1,818.41 1,580.87 1,393.29 1,134.38 850.03 667.63 193.18 Power & Fuel Cost - 62.00 60.36 47.16 6.76 4.45 2.99 0.00 2.10 1.53 0.23 % Of Sales - 0.76% 0.81% 0.85% 0.30% 0.23% 0.18% 0% 0.19% 0.18% 0.11% Employee Cost - 1,701.38 1,462.76 1,167.42 354.31 299.05 237.02 0.00 139.94 103.21 12.23 % Of Sales - 20.93% 19.54% 21.14% 15.48% 15.17% 14.36% 0% 12.89% 12.28% 5.89% Manufacturing Exp. - 129.91 165.08 131.09 11.79 10.10 2.38 0.00 4.69 4.14 3.20 % Of Sales - 1.60% 2.21% 2.37% 0.52% 0.51% 0.14% 0% 0.43% 0.49% 1.54% General & Admin Exp. - 914.90 620.52 367.12 173.51 146.50 108.14 1,243.75 65.75 42.79 18.98 % Of Sales - 11.26% 8.29% 6.65% 7.58% 7.43% 6.55% 88.40% 6.06% 5.09% 9.14% Selling & Distn. Exp. - 607.88 686.50 482.85 168.11 237.69 272.55 0.00 139.71 111.92 40.77 % Of Sales - 7.48% 9.17% 8.74% 7.35% 12.05% 16.51% 0% 12.87% 13.32% 19.63% Miscellaneous Exp. - 168.47 131.08 173.25 129.61 14.98 11.52 0.00 2.18 3.84 40.77 % Of Sales - 2.07% 1.75% 3.14% 5.66% 0.76% 0.70% 0% 0.20% 0.46% 0.01% EBITDA 2,158.93 1,697.86 1,838.49 1,372.13 470.18 390.90 257.28 272.50 235.74 172.64 14.55 EBITDA Margin 24.03% 20.89% 24.56% 24.84% 20.54% 19.82% 15.59% 19.37% 21.71% 20.55% 7.00% Other Income 225.24 162.78 203.81 154.50 43.61 30.91 33.96 23.85 19.68 19.17 0.94 Interest 11.43 28.23 47.54 8.23 1.66 1.57 1.55 0.00 1.52 2.38 1.50 Depreciation 302.61 269.58 123.33 78.19 26.55 23.78 11.47 7.76 4.44 4.20 0.59 PBT 2,070.13 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 185.24 13.41 Tax 419.92 314.58 482.01 355.83 141.38 105.88 64.53 81.70 77.44 64.69 4.85 Tax Rate 20.28% 20.13% 25.76% 24.71% 29.12% 26.71% 23.19% 28.31% 31.04% 34.92% 36.17% PAT 1,650.23 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 120.55 8.55 PAT before Minority Interest 1,650.23 1,248.26 1,389.42 1,084.37 344.20 290.57 213.69 206.89 172.02 120.55 8.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 18.37% 15.36% 18.56% 19.63% 15.04% 14.74% 12.95% 14.71% 15.84% 14.35% 4.12% PAT Growth 39.29% -10.16% 28.13% 215.04% 18.46% 35.98% 3.29% 20.27% 42.70% 1,309.94% EPS 41.19 31.16 34.68 27.07 8.59 7.25 5.33 5.16 4.29 3.01 0.21

Description TTM Mar 23 Mar 22 Mar 21
Net Sales 9,946.35 8,749.43 7,781.56 6,214.43 Net Sales Growth 18.09% 12.44% 25.22% Cost Of Goods Sold 3,146.09 2,913.64 2,421.73 1,780.60 Gross Profit 6,800.26 5,835.79 5,359.83 4,433.82 GP Margin 68.37% 66.70% 68.88% 71.35% Total Expenditure 7,585.69 6,847.50 5,791.01 4,565.32 Power & Fuel Cost - 108.96 103.13 82.53 % Of Sales - 1.25% 1.33% 1.33% Employee Cost - 1,918.47 1,620.59 1,415.78 % Of Sales - 21.93% 20.83% 22.78% Manufacturing Exp. - 150.57 189.81 140.14 % Of Sales - 1.72% 2.44% 2.26% General & Admin Exp. - 966.43 626.47 451.75 % Of Sales - 11.05% 8.05% 7.27% Selling & Distn. Exp. - 638.11 708.17 587.73 % Of Sales - 7.29% 9.10% 9.46% Miscellaneous Exp. - 151.33 121.10 106.78 % Of Sales - 1.73% 1.56% 1.72% EBITDA 2,360.64 1,901.93 1,990.55 1,649.11 EBITDA Margin 23.73% 21.74% 25.58% 26.54% Other Income 236.24 128.57 196.03 170.95 Interest 29.29 45.76 59.80 21.16 Depreciation 378.08 325.92 166.62 118.97 PBT 2,189.49 1,658.81 1,960.15 1,679.93 Tax 446.20 361.56 521.64 398.58 Tax Rate 20.38% 21.80% 26.61% 23.73% PAT 1,743.30 1,281.86 1,433.48 1,265.42 PAT before Minority Interest 1,711.52 1,309.68 1,452.96 1,293.03 Minority Interest -31.78 -27.82 -19.48 -27.61 PAT Margin 17.53% 14.65% 18.42% 20.36% PAT Growth 46.01% -10.58% 13.28% EPS 43.52 32.00 35.78 31.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 05
Shareholder's Funds 7,783.91 6,540.45 4,734.27 1,555.50 1,211.29 920.72 706.73 499.84 333.59 26.81 Share Capital 40.06 40.06 40.06 20.03 20.03 20.03 20.03 14.84 14.84 9.93 Total Reserves 7,743.79 6,500.39 4,694.21 1,535.47 1,191.26 900.69 686.70 485.00 318.76 16.89 Non-Current Liabilities 168.12 126.98 54.11 31.36 29.46 28.49 25.41 5.78 9.09 9.25 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.71 7.27 2.92 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.33 Long Term Provisions 88.87 73.79 56.39 4.84 2.08 1.98 4.64 0.00 0.00 0.00 Current Liabilities 1,419.09 2,271.27 1,078.91 593.98 540.34 474.53 364.76 233.24 171.76 51.22 Trade Payables 801.96 921.29 594.08 175.79 149.57 203.89 157.88 99.49 68.31 27.18 Other Current Liabilities 279.51 399.57 196.75 108.74 65.19 51.51 46.95 54.77 38.85 14.78 Short Term Borrowings 0.00 683.66 95.00 0.03 0.00 0.00 0.80 0.00 0.00 0.00 Short Term Provisions 337.61 266.74 193.08 309.42 325.58 219.13 159.13 78.99 64.60 9.26 Total Liabilities 9,371.12 8,938.70 5,867.29 2,180.84 1,781.09 1,423.74 1,096.90 738.86 514.44 87.28 Net Block 3,136.89 2,921.30 981.95 202.69 202.56 177.72 74.60 84.62 58.26 7.38 Gross Block 3,770.10 3,286.82 1,221.61 286.14 259.54 210.98 96.68 99.12 68.46 9.31 Accumulated Depreciation 633.21 365.51 239.65 83.45 56.98 33.26 22.08 14.50 10.20 1.92 Non Current Assets 5,854.21 5,122.99 2,777.31 568.46 529.02 383.14 195.13 248.34 148.55 7.57 Capital Work in Progress 494.78 386.57 165.57 21.37 6.44 0.43 18.11 7.30 0.21 0.19 Non Current Investment 2,040.76 1,657.08 1,500.86 109.51 87.66 27.01 12.47 156.42 90.08 0.00 Long Term Loans & Adv. 148.86 146.30 115.59 218.84 167.59 110.92 39.79 0.00 0.00 0.00 Other Non Current Assets 27.58 6.37 7.88 16.05 64.77 67.05 50.16 0.00 0.00 0.00 Current Assets 3,513.72 3,813.01 3,089.98 1,612.38 1,252.07 1,040.60 901.76 490.52 365.81 79.68 Current Investments 1,061.47 868.79 896.03 689.05 350.46 149.15 247.22 0.00 0.00 4.79 Inventories 1,032.22 1,266.69 826.91 337.19 312.67 361.73 271.93 153.55 116.63 37.66 Sundry Debtors 492.64 470.59 369.17 131.59 112.41 141.39 113.40 93.30 70.77 19.50 Cash & Bank 155.15 138.85 476.95 99.96 104.51 89.15 83.41 99.55 59.61 3.95 Other Current Assets 772.24 166.44 106.01 2.78 372.02 299.18 185.81 144.12 118.81 13.78 Short Term Loans & Adv. 668.76 901.65 414.91 351.81 372.02 299.18 184.89 144.12 118.81 13.69 Net Current Assets 2,094.63 1,541.74 2,011.07 1,018.40 711.73 566.07 537.00 257.28 194.06 28.47 Total Assets 9,367.93 8,936.00 5,867.29 2,180.84 1,781.09 1,423.74 1,096.89 738.86 514.43 87.27

Description Mar 23 Mar 22 Mar 21
Shareholder's Funds 7,435.22 6,155.23 4,722.00 Share Capital 40.06 40.06 40.06 Total Reserves 7,395.10 6,115.17 4,681.94 Non-Current Liabilities 199.24 168.68 107.33 Secured Loans 23.15 48.94 57.42 Unsecured Loans 0.00 0.25 0.25 Long Term Provisions 97.89 80.00 72.24 Current Liabilities 1,863.14 2,623.46 1,353.40 Trade Payables 1,008.18 1,076.40 666.97 Other Current Liabilities 386.05 472.89 282.77 Short Term Borrowings 115.02 794.59 158.35 Short Term Provisions 353.89 279.59 245.30 Total Liabilities 9,685.67 9,108.45 6,323.62 Net Block 4,245.28 3,582.77 1,658.94 Gross Block 5,233.03 4,246.54 2,160.04 Accumulated Depreciation 983.87 663.78 501.10 Non Current Assets 5,357.80 4,701.63 2,416.98 Capital Work in Progress 550.15 701.47 371.95 Non Current Investment 270.95 235.01 205.80 Long Term Loans & Adv. 187.54 163.88 158.07 Other Non Current Assets 98.51 13.09 16.72 Current Assets 4,324.56 4,403.84 3,906.64 Current Investments 1,075.47 874.46 1,306.17 Inventories 1,498.46 1,760.24 1,183.54 Sundry Debtors 576.42 388.17 330.61 Cash & Bank 453.20 405.94 700.74 Other Current Assets 721.01 170.74 109.78 Short Term Loans & Adv. 615.73 804.29 275.79 Net Current Assets 2,461.42 1,780.37 2,553.24 Total Assets 9,682.36 9,105.47 6,323.62

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 05
Cash From Operating Activity 1,798.99 821.44 983.38 355.00 302.53 -12.85 76.28 134.50 72.38 1.68 PBT 1,562.84 1,871.44 1,440.21 485.58 396.45 278.23 288.59 249.46 185.24 13.41 Adjustment 227.00 -4.16 96.74 -15.62 -5.64 -21.00 -14.54 -13.65 -12.29 -0.11 Changes in Working Capital 294.21 -585.61 -156.19 16.75 7.20 -185.29 -109.07 -16.87 -36.94 -6.81 Cash after chg. in Working capital 2,084.05 1,281.67 1,380.76 486.71 398.02 71.94 164.97 218.94 136.01 6.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -285.06 -460.22 -397.38 -131.71 -95.49 -84.79 -88.69 -84.44 -63.63 -4.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,040.61 -1,360.27 -1,127.16 -358.15 -285.77 20.74 -87.97 -84.29 -57.53 -2.96 Net Fixed Assets -591.49 -2,286.21 -1,079.67 -41.53 -54.57 -96.62 -8.37 -37.75 -59.17 Net Investments -576.36 -128.98 -1,598.33 -360.44 -261.96 83.53 -103.27 -66.34 -85.29 Others 127.24 1,054.92 1,550.84 43.82 30.76 33.83 23.67 19.80 86.93 Cash from Financing Activity -710.41 578.63 88.87 -1.41 -1.40 -2.15 -4.46 -10.27 -12.71 -1.12 Net Cash Inflow / Outflow 47.96 39.81 -54.91 -4.55 15.36 5.74 -16.14 39.94 2.14 -2.40 Opening Cash & Equivalents 86.17 46.36 77.50 104.51 89.15 83.41 99.55 59.61 57.47 6.33 Closing Cash & Equivalent 134.13 86.17 22.58 99.96 104.51 89.15 83.41 99.55 59.61 3.92

Description Mar 23 Mar 22 Mar 21
Cash From Operating Activity 1,813.30 919.78 1,137.24 PBT 1,671.24 1,974.60 1,691.61 Adjustment 298.43 30.81 -5.66 Changes in Working Capital 166.73 -586.12 -94.63 Cash after chg. in Working capital 2,136.40 1,419.29 1,591.32 Interest Paid 0.00 0.00 0.00 Tax Paid -323.10 -499.51 -454.07 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -1,054.13 -1,369.14 -1,222.21 Net Fixed Assets -591.49 -2,286.21 Net Investments -576.36 -128.98 Others 113.72 1,046.05 Cash from Financing Activity -739.73 604.62 -7.81 Net Cash Inflow / Outflow 19.44 155.26 -92.78 Opening Cash & Equivalents 283.06 127.33 219.73 Closing Cash & Equivalent 304.82 283.06 127.33

Financial Ratios

Standalone /

Consolidated

Description Mar 23 Mar 22 Mar 21 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10 Mar 09 Mar 05
Book Value (Rs.) 194.31 163.27 118.18 776.61 604.76 459.68 352.84 336.89 224.80 26.99 ROA 13.63% 18.77% 20.90% 17.38% 18.13% 16.96% 22.54% 27.45% 40.07% 11.44% ROE 17.43% 24.65% 25.86% 24.88% 27.26% 26.26% 34.29% 41.28% 66.91% 37.83% ROCE 21.20% 31.84% 34.16% 35.22% 37.34% 34.37% 47.66% 59.45% 99.58% 46.09% Fixed Asset Turnover 2.40 3.45 4.73 8.39 8.38 10.73 14.37 12.96 21.61 23.71 Receivable days 20.75 19.69 26.03 19.46 23.49 28.17 26.81 27.58 19.61 30.39 Inventory Days 49.52 49.10 44.95 51.82 62.42 70.06 55.19 45.41 33.51 55.67 Payable days 110.55 109.68 110.73 37.38 44.99 47.49 0.00 37.71 27.75 46.09 Cash Conversion Cycle -40.28 -40.89 -39.75 33.90 40.92 50.75 82.01 35.28 25.36 39.97 Total Debt/Equity 0.00 0.10 0.02 0.00 0.00 0.00 0.00 0.01 0.02 0.35 Interest Cover 56.36 40.37 175.93 294.17 253.23 180.56 0.00 165.50 78.96 9.96

Description Mar 23 Mar 22 Mar 21
Book Value (Rs.) 185.61 153.65 117.88 ROA 13.94% 18.83% 22.79% ROE 19.27% 26.72% 31.51% ROCE 23.49% 33.96% 39.97% Fixed Asset Turnover 1.92 2.52 3.00 Receivable days 19.33 16.25 25.31 Inventory Days 65.31 66.57 61.16 Payable days 130.57 131.38 144.73 Cash Conversion Cycle -45.92 -48.56 -58.26 Total Debt/Equity 0.02 0.14 0.05 Interest Cover 37.52 34.02 80.96

Top Investors:

hema cipef (i) limited

icici prudential mutual fund

axis mutual fund trustee limited a/c axis mutual fund

sbi nifty midcap 150 index fund

Annual Reports:

News Update:

Mankind Pharma inks pact with AstraZeneca Pharma India
11th Mar 2024, 16:25 PM

The agreement is for exclusive distribution of AstraZeneca’s budesonide and formoterol fumarate dihydrate brand Symbicort in India
Read More
Mankind Pharma’s promoters sell 1.62% stake in company
9th Feb 2024, 14:58 PM

The shares were disposed of at an average price of Rs 2,107.35 apiece, taking the combined deal value to Rs 1,367.57 crore
Read More
Mankind Pharma - Quarterly Results
31st Jan 2024, 17:32 PM

Read More

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Mankind Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543904 | NSE: MANKIND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: